Stock Earnings Analysts: CTMX stock price target of 7 in 12 months The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Recent Insider Activity Suggests Potential Gains for CytomX Therapeutics Inc (CTMX) In a filing, CytomX Therapeutics Inc revealed its Chief Financial Officer Ogden Christopher unloaded Company’s shares for reported $28540.0 on
Analysts Viewpoint CTMX (CytomX Therapeutics Inc) may reap gains as insiders became active recently CytomX Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Ogden Christopher unloaded Company’s shares for reported $28540.0 on